122
Views
0
CrossRef citations to date
0
Altmetric
Infectious Diseases

Combination of Chest Computed Tomography Value and Clinical Laboratory Data for the Prognostic Risk Evaluation of Patients with COVID-19

, , , , &
Pages 3829-3842 | Received 12 Jun 2023, Accepted 12 Aug 2023, Published online: 28 Aug 2023

References

  • Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3
  • Hu Y, Sun J, Dai Z, et al. Prevalence and severity of Corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. J Clin Virol. 2020;127:104371. doi:10.1016/j.jcv.2020.104371
  • Pepera G, Tribali MS, Batalik L, et al. Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review. Rev Cardiovasc Med. 2022;23(1):28. doi:10.31083/j.rcm2301028
  • Welch C, Greig C, Masud T, et al. COVID-19 and Acute Sarcopenia. Aging Dis. 2020;11(6):1345–1351. doi:10.14336/AD.2020.1014
  • Morley JE, Kalantar-Zadeh K, Anker SD. COVID-19: a major cause of cachexia and sarcopenia? J Cachexia Sarcopenia Muscle. 2020;11(4):863–865. doi:10.1002/jcsm.12589
  • Anker MS, Landmesser U, von Haehling S, et al. Weight loss, malnutrition, and cachexia in COVID-19: facts and numbers. J Cachexia Sarcopenia Muscle. 2021;12(1):9–13. doi:10.1002/jcsm.12674
  • Schiaffino S, Albano D, Cozzi A, et al. CT-derived Chest Muscle Metrics for Outcome Prediction in Patients with COVID-19. Radiology. 2021;300(2):E328–E336. doi:10.1148/radiol.2021204141
  • Kim JW, Yoon JS, Kim EJ, et al. Prognostic Implication of Baseline Sarcopenia for Length of Hospital Stay and Survival in Patients With Coronavirus Disease 2019. J Gerontol a Biol Sci Med Sci. 2021;76(8):e110–e116. doi:10.1093/gerona/glab085
  • Moctezuma-Velazquez P, Miranda-Zazueta G, Ortiz-Brizuela E, et al. Low Thoracic Skeletal Muscle Area Is Not Associated With Negative Outcomes in Patients With COVID-19. Am J Phys Med Rehabil. 2021;100(5):413–418. doi:10.1097/PHM.0000000000001716
  • Molwitz I, Ozga AK, Gerdes L, et al. Prediction of abdominal CT body composition parameters by thoracic measurements as a new approach to detect sarcopenia in a COVID-19 cohort. Sci Rep. 2022;12(1):6443. doi:10.1038/s41598-022-10266-0
  • Ghaznavi-Rad E, Khosravi M, Sayyadi M. The importance of using routine laboratory tests in the diagnosis and prognosis of patients with coronavirus disease 2019: shedding light on clinical laboratory data in COVID-19. J Clin Lab Anal. 2022;36(11):e24713. doi:10.1002/jcla.24713
  • Battaglini D, Lopes-Pacheco M, Castro-Faria-Neto HC, et al. Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19. Front Immunol. 2022;13:857573. doi:10.3389/fimmu.2022.857573
  • Lin Q, Wu L, Lin W, et al. Correlation between chest CT severity score and laboratory indicators in patients with Coronavirus disease 2019 (COVID-19). Int J Clin Pract. 2021;75(12):e14907. doi:10.1111/ijcp.14907
  • National Health Commission of the People’s Republic of China. Notice on Issuing the Diagnosis and Treatment Plan for Pneumonia Caused by Novel Coronavirus Infection (Trial Tenth Edition); 2019.
  • Li K, Fang Y, Li W, et al. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol. 2020;30(8):4407–4416. doi:10.1007/s00330-020-06817-6
  • Surov A, Kardas H, Besutti G, et al. Prognostic Role of the Pectoralis Musculature in Patients with COVID-19. A Multicenter Study. Acad Radiol. 2023;30(1):77–82. doi:10.1016/j.acra.2022.05.003
  • Du RH, Liang LR, Yang CQ, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020;55(5):2000524. doi:10.1183/13993003.00524-2020
  • Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020;369:m1966. doi:10.1136/bmj.m1966
  • Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021;21(1):855. doi:10.1186/s12879-021-06536-3
  • Aboueshia M, Hussein MH, Attia AS, et al. Cancer and COVID-19: analysis of patient outcomes. Future Oncol. 2021;17(26):3499–3510. doi:10.2217/fon-2021-0121
  • Lopez Bernal J, Andrews N, Gower C, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ. 2021;373:n1088. doi:10.1136/bmj.n1088
  • Ufuk F, Demirci M, Sagtas E, et al. The prognostic value of pneumonia severity score and pectoralis muscle Area on chest CT in adult COVID-19 patients. Eur J Radiol. 2020;131:109271. doi:10.1016/j.ejrad.2020.109271
  • Li C, Ye J, Chen Q, et al. Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19. Aging. 2020;12(15):15670–15681. doi:10.18632/aging.103770
  • Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364–374. doi:10.1007/s11427-020-1643-8